We are live on
!
Find out more
Calamos Advisors Portfolio holdings
AUM
$28.2B
1-Year Est. Return
21.78%
This Fund
S&P 500
This Quarter
Est. Return
+8.11%
1 Year Est. Return
+21.78%
3 Year Est. Return
+69.57%
5 Year Est. Return
+92%
10 Year Est. Return
+282.63%
AUM
$20.6B
AUM Growth
+$1.37B
(+7.1%)
Cap. Flow
-$6.1B
Cap. Flow
% of AUM
-29.59%
Top 10 Holdings %
Top 10 Hldgs %
22.72%
Holding
1,035
New
97
Increased
87
Reduced
313
Closed
112
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$63.7M |
| 2 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$52.7M |
| 3 |
HES
Hess
HES
|
+$42.5M |
| 4 |
SOVO
Sovos Brands, Inc. Common Stock
SOVO
|
+$35.1M |
| 5 |
AMED
Amedisys
AMED
|
+$22.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AESC
The AES Corporation
AESC
|
+$45.2M |
| 2 |
ATVI
Activision Blizzard
ATVI
|
+$39.1M |
| 3 |
Mercado Libre
MELI
|
+$39M |
| 4 |
DEN
Denbury Inc.
DEN
|
+$26M |
| 5 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$25.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.31% |
| 2 | Healthcare | 8.45% |
| 3 | Financials | 7.73% |
| 4 | Consumer Discretionary | 7.1% |
| 5 | Communication Services | 5.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NVO
101
Novo Nordisk
NVO
$220B
| $33.5M | 0.16% |
323,754
-8,584
| -3% | -$849K |
|
102
Booking.com
BKNG
$145B
| $33M | 0.16% |
232,875
+44,075
| +23% | +$5.5M |
|
103
Aptiv
APTV
$12.2B
| $32.6M | 0.16% |
362,798
-2,245
| -0.6% | -$193K |
|
104
American Tower
AMT
$77.7B
| $32.1M | 0.16% |
148,605
-775
| -0.5% | -$146K |
|
105
Northrop Grumman
NOC
$77.8B
| $31.9M | 0.15% |
68,108
-302
| -0.4% | -$142K |
|
106
Waste Management
WM
$95.5B
| $31.7M | 0.15% |
176,808
-164
| -0.1% | -$27.5K |
|
107
PPG Industries
PPG
$26.4B
| $31.3M | 0.15% |
209,335
-205
| -0.1% | -$27.7K |
|
108
Verizon
VZ
$198B
| $31.3M | 0.15% |
829,784
-13,399
| -2% | -$474K |
|
109
SLB Ltd
SLB
$76.5B
| $29.7M | 0.14% |
571,550
-1,629
| -0.3% | -$88.5K |
|
|
GTLS.PRB
110
DELISTED
Chart Industries 6.75% Series B Preferred Stock
GTLS.PRB
| $29.7M | 0.14% |
534,062
+40
| +0% | +$2.22K |
|
111
TSMC
TSM
$2.07T
| $29.2M | 0.14% |
281,009
-53,257
| -16% | -$5.08M |
|
112
Las Vegas Sands
LVS
$31.6B
| $29M | 0.14% |
590,249
+102,009
| +21% | +$4.82M |
|
113
Intel
INTC
$462B
| $28.8M | 0.14% |
572,916
-276,483
| -33% | -$11.2M |
|
114
Prologis
PLD
$137B
| $28.7M | 0.14% |
215,408
-4,190
| -2% | -$476K |
|
115
Vertex Pharmaceuticals
VRTX
$122B
| $28.1M | 0.14% |
69,172
-923
| -1% | -$341K |
|
116
Capri Holdings
CPRI
$1.82B
| $27.8M | 0.13% |
553,387
+68,663
| +14% | +$3.43M |
|
117
Citigroup
C
$223B
| $27.6M | 0.13% |
536,064
-3,470
| -0.6% | -$154K |
|
118
Stryker
SYK
$129B
| $27.5M | 0.13% |
91,852
+23,371
| +34% | +$6.56M |
|
119
Uber
UBER
$139B
| $27.5M | 0.13% |
446,601
-105,076
| -19% | -$5.5M |
|
120
Analog Devices
ADI
$181B
| $27.4M | 0.13% |
137,856
-20,650
| -13% | -$3.69M |
|
121
D.R. Horton
DHI
$41.3B
| $26.2M | 0.13% |
172,678
-2,252
| -1% | -$277K |
|
122
BP
BP
$109B
| $26.2M | 0.13% |
741,000
+265,525
| +56% | +$9.72M |
|
123
Sherwin-Williams
SHW
$80.7B
| $25.8M | 0.13% |
82,619
+34,928
| +73% | +$9.39M |
|
|
SCHW
124
Charles Schwab
SCHW
$181B
| $25.8M | 0.12% |
374,353
-4,890
| -1% | -$282K |
|
125
Blackrock
BLK
$165B
| $25.7M | 0.12% |
31,662
-196
| -0.6% | -$137K |
|
Similar funds
PCH
N
TWC
FDCDDQ
NA
Calamos Advisors's Q4 2023 Portfolio in Review
As of Q4 2023, Calamos Advisors held 1,035 positions worth $20.6B, up 7.1% from $19.2B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Calamos Advisors withdrew a net $6.1B in Q4 2023, closing 112 positions and reducing 313 holdings. Its most notable exit was The AES Corporation, an estimated $45.2M position sold in full.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Calamos Advisors opened a new position in Amedisys worth $23M.
- Calamos Advisors's largest Q4 2023 buy was Amedisys: 242,110 shares worth $23M.
- Calamos Advisors added most to Tesla in Q4 2023, an estimated $63.7M increase.
- Calamos Advisors's biggest Q4 2023 reduction was Mercado Libre, cutting an estimated $39M.
- Calamos Advisors fully exited The AES Corporation in Q4 2023, selling an estimated $45.2M.
- Calamos Advisors's ten largest holdings make up 23% of its $20.6B portfolio in Q4 2023.
- Calamos Advisors opened 97 new positions and closed 112 in Q4 2023.
- Calamos Advisors's portfolio value rose 7.1% quarter-over-quarter to $20.6B.
Based on Calamos Advisors's 13F filing for Q4 2023, filed 31 Jan 2024.